No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
190 |
4. Check minimum number of eventsNone |
190 |
5. Include endpointsNone |
190 |
6. Filter based on genotype QC (FinnGen only) |
190 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Marfan's syndrome
based on the number of shared cases.
Similar with more cases:
- Other specified congenital malformation syndromes affecting multiple systems
- Exclusion endpoint for clefts
- Clefts and syndromes for tooth agenesis exclusion, including avohilmo
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 190 | 92 | 98 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | 35.69 | 33.84 | 37.43 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
101
311
5.80
32.75
4.5
3.0
ng/l
858.6
906.6
0.08
91
258
(3022217) INR in Platelet poor plasma by Coagulation assay
55
127
5.69
23.89
62.7
18.6
inr
1.9
1.2
—
5
18
(3032080) INR in Blood by Coagulation assay
117
503
4.45
22.89
31.6
6.8
inr
2.1
1.2
4.90
28
153
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
30
9.88
21.17
6.3
2.5
u/ml
0.3
0.3
0.01
15
17
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
235
4.13
18.66
3.4
2.9
ng/l
2277.9
321.5
0.98
59
162
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
45
133
4.12
13.93
2.3
4.0
u/l
286.1
236.2
1.65
45
128
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
29
60
5.52
13.83
17.3
6.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
23
44
5.81
11.87
3.6
1.7
%
159.2
166.2
0.18
23
44
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
24
51
5.24
11.05
1.6
1.9
g/l
1.2
1.4
0.40
16
45
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
24
52
5.14
10.81
3.1
1.6
%
84.5
96.4
1.33
24
52
(3000991) Gas panel - Venous blood
35
107
3.78
10.18
17.1
6.7
—
—
—
0
0
(3044889) 12 lead EKG panel
148
1014
3.08
9.84
5.4
3.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
27
78
3.87
8.45
17.1
5.3
mmol/l
25.3
24.7
0.35
27
78
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
64
308
2.63
8.45
2.5
2.0
mg/l
2.9
2.9
0.03
57
271
(3023368) Bacteria identified in Blood by Culture
68
338
2.58
8.40
5.6
4.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
11
9.54
8.16
1.2
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
23
61
4.15
8.07
23.0
7.3
mmol/l
24.0
24.2
0.13
23
54
(3016502) Oxygen saturation in Arterial blood
34
121
3.20
7.76
19.9
7.2
%
97.6
96.1
2.21
34
116
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
25
5.97
7.66
1.4
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
62
313
2.46
7.26
2.3
1.7
mg/l
2.1
1.0
1.25
48
244
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
35
133
3.00
7.13
19.7
6.7
kpa
5.3
5.2
0.06
35
125
(3027801) Oxygen [Partial pressure] in Arterial blood
35
133
3.00
7.13
19.5
6.7
kpa
13.7
12.8
0.36
35
127
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
25
80
3.45
6.72
23.9
7.7
%
1.3
1.7
1.06
25
80
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
25
80
3.45
6.72
24.4
7.6
%
0.6
0.7
0.74
25
80
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
90
562
2.14
6.16
11.6
5.8
mmol/l
1.2
1.2
3.05
85
520
(3024928) Oxygen saturation in Venous blood
12
24
5.27
5.82
3.8
2.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
76
457
2.11
5.63
3.3
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
95
621
2.06
5.62
11.1
6.6
mmol/l
1.2
1.2
2.84
80
535
(42870588) Differential panel, method unspecified - Blood
78
483
2.04
5.27
4.7
6.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
60
341
2.11
5.07
3.5
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
67
398
2.06
5.03
7.0
7.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
38
180
2.39
4.97
5.3
6.5
mmol/l
1.0
1.0
0.22
38
163
(3002582) Erythrocytes [#/volume] in Urine
69
417
2.03
4.93
3.1
2.9
e6/l
1603.7
64.9
0.47
55
311
(3001122) Ferritin [Mass/volume] in Serum or Plasma
99
685
1.93
4.73
3.2
2.6
ug/l
203.4
119.7
0.65
89
646
(3022096) Basophils/100 leukocytes in Blood
99
687
1.92
4.67
5.5
6.1
%
0.6
0.7
0.41
92
642
(3018418) pH of Serum or Plasma
63
376
2.01
4.61
3.8
4.2
ph
7.4
7.4
0.03
15
63
(3018095) Leukocytes [#/volume] in Urine
77
494
1.94
4.57
3.5
3.4
e6/l
49.3
43.7
0.10
57
333
(3019230) Fractional oxyhemoglobin in Venous blood
10
22
4.74
4.35
2.3
2.1
%
57.4
70.2
—
10
22
(3006504) Eosinophils/100 leukocytes in Blood
99
708
1.83
4.07
5.5
6.1
%
3.3
2.8
1.34
92
663
(3000850) Epithelial cells [#/volume] in Urine
50
286
2.02
4.06
2.7
2.5
e6/l
3.4
4.3
0.43
43
248
(40765089) Chromosome analysis panel - Blood by G-banded
7
7
10.32
4.04
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
96
683
1.82
3.99
5.1
3.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
99
713
1.81
3.93
5.7
6.3
%
9.1
8.3
2.06
92
675
(3002030) Lymphocytes/100 leukocytes in Blood
101
737
1.79
3.80
5.5
6.0
%
24.5
28.8
3.88
94
698
(3012544) pH of Venous blood
26
118
2.39
3.71
4.5
3.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
99
731
1.74
3.47
5.4
5.9
%
58.8
56.8
0.94
92
692
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
71
482
1.76
3.31
3.0
3.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
167
1458
2.20
3.23
21.2
10.4
ml/min/173m2
94.9
89.8
2.16
146
1182
(3002256) Pathology report gross observation
31
162
2.09
3.18
1.2
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
18
74
2.58
3.15
3.8
3.4
g/l
134.6
130.8
0.20
18
74
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
69
472
1.73
3.10
1.8
1.7
pmol/l
97.2
95.6
0.10
36
248
(36304419) Bacteria [Presence] in Urine
59
389
1.75
3.01
2.8
2.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
79
570
1.66
2.87
2.6
2.3
nmol/l
80.2
73.6
1.12
71
514
(3001604) Monocytes [#/volume] in Blood
100
768
1.64
2.83
5.6
6.1
e9/l
0.6
0.6
0.01
90
668
(3026782) Osmolality of Urine
43
263
1.82
2.80
2.2
2.4
mosm/kgh2o
549.1
569.7
0.22
37
219
(3006315) Basophils [#/volume] in Blood
100
770
1.63
2.79
5.6
6.1
e9/l
0.0
0.0
1.12
90
670
(3021589) Normoblasts [#/volume] in Blood
90
677
1.63
2.74
9.6
8.5
e9/l
0.0
0.0
0.19
76
543
(3013115) Eosinophils [#/volume] in Blood
102
794
1.61
2.69
5.7
6.7
e9/l
0.2
0.2
0.74
91
712
(3042936) Bacteria identified in Isolate by Culture
36
211
1.87
2.68
2.2
2.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
101
792
1.59
2.53
5.5
6.1
e9/l
1.5
1.9
5.00
90
709
(3005033) Fetal Nuchal fold Thickness US
0
64
0.00
2.48
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
64
0.00
2.48
0.0
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
134
1127
1.64
2.48
8.2
7.3
u/l
81.3
76.7
0.34
125
1066
(3047181) Lactate [Moles/volume] in Blood
10
34
3.05
2.45
7.4
5.6
mmol/l
1.2
1.2
—
10
29
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
67
0.00
2.44
0.0
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
46
2.72
2.41
1.1
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
56
386
1.64
2.37
3.0
2.7
e6/l
0.2
0.4
0.58
46
279
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
107
2.08
2.31
3.1
2.3
ml/min/173m2
83.1
67.7
—
9
49
(3031040) Bacteria [#/volume] in Urine by Automated count
113
922
1.56
2.29
4.9
3.9
e6/l
1172.6
18.3
—
5
10
(3022313) Gas panel - Capillary blood
14
60
2.44
2.28
3.8
3.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
42
274
1.68
2.18
1.6
1.4
nmol/l
18.5
20.7
0.43
34
236
(3021901) Oxygen saturation in Capillary blood
7
19
3.78
2.17
4.6
2.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
110
901
1.52
2.13
7.9
9.9
e9/l
4.0
4.1
0.15
100
787
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
173
1583
2.04
2.12
22.3
11.6
mg/l
35.7
22.7
3.27
142
1205
(3004588) Protein electrophoresis panel - Serum or Plasma
16
76
2.21
2.09
1.6
2.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
67
495
1.55
2.09
5.4
3.2
ng/l
36.8
41.3
0.12
49
292
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
34
212
1.74
2.07
2.4
2.6
e6/l
1.9
1.9
0.01
24
109
(3026008) Bacteria identified in Urine by Culture
49
337
1.61
2.07
2.8
2.5
—
—
—
0
0
(3000492) Spirometry study
28
166
1.81
2.01
1.6
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
33
206
1.73
2.00
1.9
1.6
nmol/l
1132.7
1207.2
0.19
28
162
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
21
114
1.95
1.96
2.9
5.0
ug/l
4.9
47.1
0.53
11
87
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
27
3.05
1.96
1.4
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
16
3.84
1.95
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
131
1.86
1.88
4.0
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
35
2.65
1.82
1.2
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
88
2.02
1.81
1.1
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
13
3.92
1.72
1.6
1.5
pg
31.4
34.0
—
5
13
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
13
3.92
1.72
1.0
1.7
g/l
1.0
1.0
—
5
13
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
151
1.75
1.70
1.2
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
31
2.65
1.68
1.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
31
2.65
1.68
1.0
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
50
2.27
1.60
1.8
1.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
20
3.06
1.59
1.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
57
2.18
1.58
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
14
252
0.52
1.57
1.4
2.0
%
1.8
1.4
0.61
14
230
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
33
2.49
1.55
1.3
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
15
3.39
1.53
1.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
27
2.65
1.53
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
21
2.92
1.52
1.0
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
9
37
2.50
1.50
2.0
2.0
g/l
0.0
0.0
—
9
37
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
24
149
1.70
1.50
3.0
2.7
u/l
30.0
32.7
0.20
24
122
(40761511) CBC panel - Blood by Automated count
179
1692
2.00
1.44
19.8
10.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
55
424
1.42
1.32
1.7
2.6
u/l
53.0
56.6
0.52
49
403
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
43
2.15
1.32
1.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
69
1.95
1.32
1.2
1.3
—
—
—
0
0
(4268621)
6
24
2.55
1.31
2.0
2.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
5
18
2.82
1.29
1.8
1.6
mmol/l
1.5
1.6
—
5
18
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
44
2.10
1.28
2.0
1.9
g/l
37.5
39.1
—
9
38
(3025130) Human papilloma virus identified in Specimen
6
25
2.44
1.25
1.2
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
53
411
1.40
1.23
1.2
1.3
u/ml
0.5
1.2
1.76
16
111
(3032773) Endomysium IgG Ab [Titer] in Serum
5
19
2.67
1.22
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
19
2.67
1.22
1.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
234
1.50
1.22
2.4
2.5
e6/l
0.7
0.9
0.10
22
130
(3052851) Hemolysis interference index of Serum or Plasma
8
39
2.10
1.17
4.1
2.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
58
461
1.37
1.16
1.5
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
56
443
1.37
1.15
5.4
3.3
mmol/l
2.3
2.3
0.80
50
401
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
30
2.38
1.13
3.1
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
40
2.04
1.13
2.8
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
166
1557
1.52
1.12
26.8
11.8
%
40.0
41.2
2.32
136
1275
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
7
31
2.30
1.11
1.9
2.8
mg/l
23.9
25.0
—
7
26
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
31
2.30
1.11
2.0
2.8
mg/l
36.6
224.3
—
7
26
(3037467) Urinalysis macro (dipstick) panel - Urine
116
1028
1.33
1.10
4.0
3.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
151
1395
1.40
1.07
4.7
4.3
mu/l
1.8
1.8
0.17
142
1299
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
75
1.79
1.05
2.2
2.5
u/l
666.1
3565.3
—
6
27
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
60
1.88
1.05
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.1
—
1.6
—
0
7
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
211
1.44
0.96
1.8
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
31
229
1.42
0.94
1.5
1.7
pmol/l
389.7
453.4
0.76
25
209
(3013512) EKG study
45
356
1.35
0.92
4.4
3.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
16
103
1.60
0.91
5.6
3.4
pmol/l
4.6
4.8
0.51
16
93
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
29
2.10
0.90
1.0
1.5
—
—
—
0
0
(4306422)
6
29
2.10
0.90
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
56
1.83
0.89
1.8
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
22
154
1.48
0.88
1.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
269
0.67
0.85
1.1
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
57
1.80
0.85
1.8
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
66
1.71
0.80
1.8
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
33
1.84
0.79
1.8
2.4
kpa
8.7
8.6
—
6
33
(3013290) Carbon dioxide [Partial pressure] in Blood
6
33
1.84
0.79
1.8
2.4
kpa
4.8
5.1
—
6
33
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
127
1166
1.27
0.79
4.0
3.7
pmol/l
15.1
14.5
1.42
119
1073
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
26
0.00
0.79
0.0
1.3
—
7.5
—
0
17
(40768800) Prostate Pathology biopsy report
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
27
0.00
0.78
0.0
21.4
—
1510.1
—
0
27
(1761868) Lipid panel - Serum or Plasma
56
658
0.79
0.75
2.3
2.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
24
2.11
0.75
2.6
3.0
e9/l
3.2
4.1
—
5
24
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
24
2.11
0.75
2.6
3.7
%
59.6
56.7
—
5
24
(4010399)
6
108
0.54
0.75
1.5
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
109
0.54
0.75
1.5
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
312
1.31
0.75
2.0
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
92
1.56
0.74
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
58
1.58
0.71
1.9
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
24
180
1.38
0.69
1.4
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
42
1.69
0.69
1.0
1.2
—
1.8
—
0
8
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
42
1.69
0.69
1.0
1.2
—
3.5
—
0
7
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
111
1204
0.81
0.69
2.5
3.0
u/l
50.1
43.3
0.26
105
1151
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
129
0.60
0.66
1.6
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
30
237
1.32
0.63
2.2
2.3
ug/g
83.6
108.6
0.43
24
192
(3007164) IgA [Mass/volume] in Serum or Plasma
46
385
1.26
0.63
1.3
1.3
g/l
2.3
2.2
0.10
17
254
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
22
0.00
0.59
0.0
1.7
—
13.2
—
0
22
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
73
1.54
0.57
13.6
4.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
36
1.69
0.57
1.0
1.3
—
20.9
—
0
6
(3020630) Protein [Mass/volume] in Serum or Plasma
13
90
1.48
0.57
1.8
2.9
g/l
65.1
67.1
0.29
13
82
(1002224) Polysomnography panel
13
90
1.48
0.57
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
204
0.71
0.56
1.2
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
66
582
1.21
0.56
1.9
1.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
9
59
1.55
0.56
3.8
3.3
%
43.5
52.8
—
9
59
(3012516) Albumin [Mass/volume] in Urine
28
342
0.79
0.51
3.3
3.4
mg/l
125.7
65.4
0.31
18
219
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
145
1.34
0.51
1.7
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
362
0.80
0.50
3.4
4.0
mg/mmol
13.7
8.8
0.25
18
230
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
243
0.76
0.49
1.6
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
14
102
1.40
0.49
3.9
4.2
ng/l
106.3
84.1
0.59
14
94
(3049717) Cytology report of Urine Cyto stain
7
47
1.51
0.48
1.4
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
116
0.68
0.47
2.1
3.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
84
0.58
0.46
2.6
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
20
157
1.31
0.45
1.4
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
140
0.70
0.45
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
238
0.78
0.43
1.5
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
31
1.63
0.43
1.6
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
31
1.63
0.43
1.0
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
33
279
1.22
0.42
2.1
2.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
33
1.53
0.41
5.4
3.6
—
1018.0
—
0
5
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.3
—
1.8
—
0
12
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
159
0.74
0.40
1.4
2.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
33
383
0.83
0.39
3.0
3.9
%
25.6
21.6
—
9
165
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
143
1.29
0.38
1.7
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
265
0.81
0.37
1.4
1.3
u/ml
10.7
5.0
—
6
108
(3003740) Influenza virus B Ag [Presence] in Specimen
6
42
1.44
0.36
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
42
1.44
0.36
1.3
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
118
1121
1.14
0.35
4.7
3.6
mm/h
11.7
9.6
0.65
107
1044
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
389
0.85
0.34
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
187
0.79
0.34
2.1
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
154
0.76
0.33
8.6
7.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
119
1.28
0.33
5.9
2.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
22
184
1.22
0.32
1.9
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
68
735
0.88
0.32
5.4
4.2
estimate
0.0
0.0
0.00
17
133
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
56
1.26
0.30
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
52
569
0.88
0.29
4.5
3.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
103
1.28
0.29
1.0
1.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
70
746
0.90
0.25
4.2
3.1
estimate
0.0
0.0
0.00
16
124
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.4
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.4
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
95
0.73
0.23
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
21
182
1.17
0.22
1.4
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
41
1.23
0.22
1.2
1.5
g/l
0.6
0.5
—
5
35
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
25
282
0.87
0.22
1.2
1.3
iu/ml
16.9
24.2
—
5
85
(3027944) Amphetamines [Presence] in Urine
8
103
0.77
0.21
1.3
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(44813793)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4198724)
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(4146454)
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
123
0.80
0.21
1.3
1.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
48
1.26
0.20
1.2
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
270
1.13
0.20
1.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
90
1.24
0.19
2.3
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
279
0.88
0.19
1.6
2.6
ug/l
0.6
0.7
1.01
15
161
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
120
1237
0.92
0.19
3.2
3.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
53
1.14
0.19
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
58
1.21
0.18
1.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
60
1.17
0.18
1.3
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
80
1.13
0.15
2.4
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
82
1.10
0.15
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
106
0.84
0.13
1.3
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
11
127
0.86
0.13
3.8
2.3
—
26.5
—
0
6
(46235355) HIV 1 and 2 tests - Meaningful Use set
46
436
1.07
0.12
1.7
2.0
—
—
—
0
0
(4035726)
13
115
1.14
0.11
1.2
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
145
1472
0.94
0.11
3.5
3.7
mmol/l
5.8
5.8
0.07
134
1374
(3029937) Albumin [Presence] in Urine by Test strip
40
381
1.06
0.09
4.7
3.4
estimate
0.0
0.0
0.50
15
128
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
6
57
1.05
0.08
1.2
1.3
g/l
0.2
0.2
—
6
57
(3015736) pH of Urine
59
570
1.05
0.08
3.6
3.0
—
—
—
0
0
(3020891) Body temperature
6
58
1.04
0.08
18.0
5.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
61
0.81
0.08
2.0
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
160
1583
1.07
0.08
4.0
4.2
mmol/l
2.7
2.8
1.20
151
1492
(3011288) Drugs identified in Urine by Screen method
5
65
0.76
0.08
26.6
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
70
0.85
0.08
2.0
2.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
158
1564
1.06
0.07
3.7
3.8
mmol/l
1.3
1.4
3.95
151
1474
(3000764) Benzodiazepines [Presence] in Urine
9
102
0.88
0.06
2.4
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
103
0.87
0.06
2.4
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
104
0.86
0.06
2.4
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
336
1.05
0.06
2.9
3.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
153
1518
1.04
0.04
3.4
3.5
mmol/l
1.3
1.3
0.13
145
1422
(40760892) CBC W Ordered Manual Differential panel - Blood
36
371
0.96
0.03
4.3
4.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
72
732
0.97
0.03
4.1
3.0
estimate
0.0
0.0
0.00
17
131
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
158
1570
1.04
0.03
3.8
3.9
mmol/l
4.5
4.7
2.50
151
1487
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
261
1.04
0.03
1.3
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
349
0.97
0.02
1.5
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
32
312
1.03
0.02
4.3
3.4
kg/l
1.0
1.0
—
5
36
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
99
1.01
0.00
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
171
1705
1.03
0.00
10.8
9.1
u/l
26.9
28.5
0.36
165
1656
(3019225) pH of Specimen
12
115
1.05
0.00
2.6
4.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
10
105
0.95
0.00
2.6
4.4
—
0.4
—
0
23
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
51
0.98
0.00
1.2
2.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
8
0.00
0.00
0.0
1.6
—
0.2
—
0
8
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
56
0.89
0.00
3.0
2.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
10.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
17.0
—
0
7
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
11.0
—
0
5
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
7.7
—
0
6
(40768446) Kidney Pathology biopsy report
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
67
0.89
0.00
2.2
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
6
60
1.00
0.00
1.2
1.3
g/l
1.1
1.2
—
6
60
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
5.9
—
0
6
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
1810.0
—
0
5
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
9
0.00
0.00
0.0
2.8
—
16.9
—
0
9
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.3
—
114.0
—
0
7
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
1.2
—
0
7
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
42
420
1.00
0.00
4.4
2.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
13.5
—
0
6
(3016879) Cocaine [Presence] in Urine
9
98
0.91
0.00
2.4
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_MARFAN – Marfan's syndrome
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).